S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Reproductive Endocrinologist Dr. Wes Urian Joins Pinnacle Fertility

Pinnacle Fertility Washington has expanded its Seattle clinical team with the appointment of Dr. John Wesley "Wes" Urian, a fellowship-trained reproductive endocrinologist. Dr. Urian, who previously completed his residency at Oregon Health & Science University, joins the network to focus on personalized, inclusive fertility care for Pacific Northwest patients.

Reproductive Endocrinologist Dr. Wes Urian Joins Pinnacle Fertility
Photo: Bio & News

Dr. Urian arrives at the Seattle clinic following a fellowship in Reproductive Endocrinology and Infertility at UPMC Magee-Womens Hospital. His clinical background includes specialized research into assisted reproductive technology, particularly concerning metabolic health and the influence of vitamin D on pregnancy outcomes. In 2021, his work earned him the Nutrition Prize Paper Award at the American Society for Reproductive Medicine Scientific Congress.

Medical Director Dr. Amanda Hurliman noted that Urian’s recruitment aligns with the network’s goal of providing highly tailored patient support. Beyond his clinical focus, Urian is an active member of the ASRM’s LGBTQ Special Interest Group, emphasizing his commitment to providing affirming care for diverse paths to parenthood. He is currently accepting new patients at the Seattle facility, where he joins a broader regional network of clinics that have served the Pacific Northwest for over two decades.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!